SCHEMBL3569656

SCHEMBL3569656

O=C(NC1CCCCC1)C1=C(c2ccccc2)c2ccc(OCCN3CCOCC3)cc2/C1=N/O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 8/20 0.70
HRH3 Q9Y5N1 2/20 0.52
HTR3E A5X5Y0 1/20 0.52
HTR3B O95264 1/20 0.52
HTR3A P46098 1/20 0.52
HTR3D Q70Z44 1/20 0.52
HTR3C Q8WXA8 1/20 0.52
BMPR1B O00238 1/20 0.51
BMPR1A P36894 1/20 0.51
TGFBR1 P36897 1/20 0.51
ACVRL1 P37023 1/20 0.51
ACVR1 Q04771 1/20 0.51
KMT2A Q03164 2/20 0.49
EPHX2 P34913 2/20 0.49
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
MEN1 O00255 1/20 0.47
GAA P10253 1/20 0.47
NR2F2 P24468 1/20 0.47
RAD52 P43351 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3569658 1.00 PPARG (0.70) PPARGHRH3HTR3EHTR3BHTR3A
SCHEMBL3574590 0.90 PPARG (0.73) PPARGHRH3BMPR1BBMPR1ATGFBR1
SCHEMBL13316081 0.87 PPARG (0.92) PPARGHRH3BMPR1BBMPR1ATGFBR1
SCHEMBL4823811 0.86 PPARG (0.68) PPARGHRH3BMPR1BBMPR1ATGFBR1
SCHEMBL4889178 0.84 PPARG (0.64) PPARGHRH3BMPR1BBMPR1ATGFBR1
SCHEMBL3572485 0.83 PPARG (0.61) PPARGBMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL13316096 0.82 PPARG (1.00) PPARGBMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL3569503 0.80 PPARG (0.60) PPARGBMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL4659809 0.77 PPARG (0.57) PPARGBMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL13316095 0.74 PPARG (1.00) PPARGHRH3NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745439-B2 Indene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-29 US disclosed
EP-1756036-A4 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF KOREA RES INST CHEM TECH (KR) 2008-04-16 EP disclosed
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof JEIL PHARM. CO., LTD. (KR) 2007-09-27 US disclosed
EP-1756036-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF Korea Research Institute of Chemical Technology (KR) 2007-02-28 EP disclosed
WO-2005100297-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof INSR, GPR119, PPARA PPARG 8/4885HRH3 829/4885HTR3E 1414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.